Hepatology

Researchers at the 5th World Congress on Hepatitis & Liver Diseases discussed the 10-year forecast for hepatitis C virus, as well as the goals set forth by the World Health Organization to significantly...

While data has suggested that nonalcoholic fatty liver disease could be associated with early heart failure, the relationship between nonalcoholic steatohepatitis and changes in cardiac structure and...

Testing for elevated liver enzymes should be deliberate and focused, as limited testing can save time and money and prevent false positives.

The American College of Gastroenterology recently released new guidelines, the first in 10 years, on the evaluation of abnormal liver chemistries.

A new study extended the period of treatment for patients with Hepatitis C on Sofosbuvir and Ribavirin to test whether SVF12 rates can be attained in real-life.

Researchers assessed direct-acting antiviral agents and availability of funding to determine the impact on ability to treat and cure veterans with hepatitis C virus.

A fixed dose of elbasvir-grazoprevir, with or without ribavirin, is well tolerated in patients with hepatitis C virus genotypes 1, 4, or 6.

A new study assessed the impact of treatment status on the risk of hepatocellular carcinoma in patients with hepatitis C virus.

A recent study aimed to determine the impact of treatment adherence to sofosbuvir-based regimens on virological outcomes in patients with hepatitis C virus.

Research discussed at an international symposium suggests that treating people who use drugs and have hepatitis C virus can reduce the prevalence of the infection. However, barriers prevent this population...